UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Amphastar Pharmaceuticals is implementing good security practices.
Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures and sells inhalation and intranasal products.
This report shows a preliminary security rating for Amphastar Pharmaceuticals. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
Globalization and increasing regulatory pressure means more organizations need to examine their ...
The Domain Name System Security Extensions (DNSSEC or DNS Security Extensions) is a set of Internet ...
Compare Amphastar Pharmaceuticals's security performance with other companies